I M Rohrbach1, S Starc, M Knorr
1Universitäts-Augenklinik Tübingen.
Histological and immunohistological markers do not predict pterygium recurrence after surgery. This finding limits the ability to identify patients who might benefit from adjuvant therapies like mitomycin C or beta-irradiation.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: